Cell cycle distribution of cells treated with etoposide in the presence or absence of NU7026
. | 24 h . | . | . | 48 h . | . | |||
---|---|---|---|---|---|---|---|---|
Cell cycle phase . | NU7026 . | Etoposide . | Etoposide + NU7026 . | Etoposide . | Etoposide + NU7026 . | |||
G1, % | 71 | 34 | 16 | 32 | 14 | |||
S, % | 12 | 11 | 10 | 40 | 37 | |||
G2/M, % | 13 | 51 | 62 | 16 | 44 |
. | 24 h . | . | . | 48 h . | . | |||
---|---|---|---|---|---|---|---|---|
Cell cycle phase . | NU7026 . | Etoposide . | Etoposide + NU7026 . | Etoposide . | Etoposide + NU7026 . | |||
G1, % | 71 | 34 | 16 | 32 | 14 | |||
S, % | 12 | 11 | 10 | 40 | 37 | |||
G2/M, % | 13 | 51 | 62 | 16 | 44 |
Cells were treated with etoposide (0.4 μM) in the presence or absence of NU7026 (10 μM) for 24 or 48 hours, then harvested for flow cytometric analysis. Data are the means of duplicate samples from a representative experiment.